Oral Barrier Immuno-Surviellance; alterations across the life-course
口腔屏障免疫监视;
基本信息
- 批准号:BB/M025977/1
- 负责人:
- 金额:$ 123.5万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Fellowship
- 财政年份:2016
- 资助国家:英国
- 起止时间:2016 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
As we age, the systems of our bodies become less well able to function; rendering fit and active people increasingly infirm. It has been predicted that by 2050 there will be ~19 million people in the UK over 65 years of age. With enhanced numbers of elderly people, there becomes an increasing need to develop strategies to promote "healthy ageing", limiting the negative consequences of ageing.One important system affected by ageing, is our immune system, influencing our ability to both fight infection and maintain tolerance. This is a particular problem at barrier sites, interfaces between the internal body and the external world (such as the gut and oral cavity). The immune system at these sites has to mediate a delicate balance; it must protect against pathogen entry and also be able to distinguish these bad invaders from commensal/friendly bacteria. This is a difficult challenge and to achieve this the immune system is carefully tailored to barrier sites creating highly specialized networks of immune cells that enforce this balance and ensure the integrity of barrier sites. Maintaining this balance becomes increasingly difficult with advancing age. Although age-driven changes in immune function have been assessed in the gut, the influence of age on the immune network present at the oral barrier remains minimally explored. This is a significant oversight given that advancing age is accompanied by loss of oral barrier integrity and an increased incidence and severity of oral inflammation. Moreover, recent data has shown that oral inflammation is a risk factor for a plethora of disorders associated with unhealthy aging, including cardiovascular disease and diabetes. As such it becomes increasingly important to understand the age-associated changes occurring at the oral barrier. The objectives of this grant are to determine the functional changes to oral barrier immune responses with age and to define the oral-specific factors that educate the oral barrier immune network across a life-time. By employing novel techniques that I have developed alongside cutting edge-technology, this work will transform our understanding of tissue-specific control of immune homeostasis at the oral barrier throughout a healthy life-time. In particular this work will assess the factors that promote immune dys-regulation at the oral barrier and undermine barrier homeostasis with age. This research will be undertaken at the University of Manchester (UoM), in the Faculty of Life Sciences (FLS) and the new Manchester Collaborative Centre for Inflammation Research. Employing human samples and complimentary mouse models, this research programme will interrogate the core mechanisms underlying immune tailoring at the oral barrier. This work will be supported by a number of collaborators, both within the UK and globally, whose expertise will greatly enhance the efficiency with which this work is undertaken and whose resources will increase the scope of the work undertaken. I have established a clinical collaboration with Prof. J. Yates (at the UoM), who has helped me to develop clinical cohorts allowing me to obtain tissue samples from the oral barrier of healthy people of different ages. Complimentary to this, a key international collaborator is Prof. D. Bowdish (McMaster University, Canada), an expert in immunological ageing, who will provide me with access to aged-mouse cohorts. Additional collaborators in this research programme are experts in their fields Dr. Y Belkaid (NIAID, NIH, USA) and Prof. W. Muller (UoM, UK). These innovative studies will elevate our fundamental understanding of the immune cell network promoting oral barrier integrity. Identifying mechanisms that change during ageing and the factors that promote these changes presents a window of therapeutic opportunity to reinforce the integrity of an aged oral barrier, limit oral inflammation and therefore safeguard systemic health, throughout the life-span of an organism.
随着年龄的增长,我们身体的系统功能变得越来越差;使健康和活跃的人越来越虚弱。据预测,到2050年,英国将有1900万人超过65岁。随着老年人人数的增加,越来越需要制定战略,促进“健康老龄化”,限制老龄化的负面影响,受老龄化影响的一个重要系统是我们的免疫系统,影响我们抵抗感染和保持耐受性的能力。这是一个特别的问题,在屏障部位,内部身体和外部世界之间的界面(如肠道和口腔)。这些部位的免疫系统必须调解一种微妙的平衡;它必须防止病原体进入,并能够区分这些有害的入侵者和有害/友好的细菌。这是一个困难的挑战,为了实现这一目标,免疫系统被仔细地定制为屏障部位,从而创建高度专业化的免疫细胞网络,这些免疫细胞网络强制实现这种平衡并确保屏障部位的完整性。随着年龄的增长,保持这种平衡变得越来越困难。尽管已经在肠道中评估了年龄驱动的免疫功能变化,但年龄对口腔屏障免疫网络的影响仍然很少。这是一个重大的疏忽,因为年龄的增长伴随着口腔屏障完整性的丧失以及口腔炎症的发生率和严重程度的增加。此外,最近的数据表明,口腔炎症是与不健康衰老相关的多种疾病的风险因素,包括心血管疾病和糖尿病。因此,了解口腔屏障发生的与年龄相关的变化变得越来越重要。这项资助的目的是确定口腔屏障免疫反应随年龄的功能变化,并确定在一生中培养口腔屏障免疫网络的口腔特异性因素。通过采用我与尖端技术一起开发的新技术,这项工作将改变我们对整个健康生活中口腔屏障免疫稳态组织特异性控制的理解。特别是这项工作将评估促进口腔屏障免疫失调和破坏屏障稳态随年龄增长的因素。这项研究将在曼彻斯特大学(UoM),生命科学学院(FLS)和新的曼彻斯特炎症研究合作中心进行。采用人类样本和免费的小鼠模型,这项研究计划将询问在口腔屏障免疫剪裁的核心机制。这项工作将得到联合王国和全球许多合作者的支持,他们的专业知识将大大提高这项工作的效率,他们的资源将扩大所开展工作的范围。我已经与J. Yates教授(在UoM)建立了临床合作,他帮助我开发了临床队列,使我能够从不同年龄的健康人的口腔屏障中获得组织样本。与此同时,一个重要的国际合作者是D。Bowdish博士(加拿大麦克马斯特大学)是一位免疫衰老方面的专家,他将为我提供老年小鼠队列。本研究项目的其他合作者是各自领域的专家Y Belkaid博士(NIAID,NIH,美国)和W。Muller(UoM,UK).这些创新的研究将提升我们对促进口腔屏障完整性的免疫细胞网络的基本理解。确定在衰老过程中发生变化的机制以及促进这些变化的因素,为加强老年口腔屏障的完整性,限制口腔炎症,从而在生物体的整个生命周期内保护全身健康提供了一个治疗机会。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Macrophages in gastrointestinal homeostasis and inflammation.
- DOI:10.1007/s00424-017-1958-2
- 发表时间:2017-04
- 期刊:
- 影响因子:0
- 作者:Grainger JR;Konkel JE;Zangerle-Murray T;Shaw TN
- 通讯作者:Shaw TN
Does the Microbiome Affect the Outcome of Renal Transplantation?
- DOI:10.3389/fcimb.2020.558644
- 发表时间:2020
- 期刊:
- 影响因子:5.7
- 作者:Campbell PM;Humphreys GJ;Summers AM;Konkel JE;Knight CG;Augustine T;McBain AJ
- 通讯作者:McBain AJ
Isolation, Characterization and Functional Examination of the Gingival Immune Cell Network.
- DOI:10.3791/53736
- 发表时间:2016-02-16
- 期刊:
- 影响因子:0
- 作者:Dutzan N;Abusleme L;Konkel JE;Moutsopoulos NM
- 通讯作者:Moutsopoulos NM
On-going Mechanical Damage from Mastication Drives Homeostatic Th17 Cell Responses at the Oral Barrier.
咀嚼性持续的机械损害驱动稳态Th17细胞反应在口腔屏障处。
- DOI:10.1016/j.immuni.2016.12.010
- 发表时间:2017-01-17
- 期刊:
- 影响因子:32.4
- 作者:Dutzan N;Abusleme L;Bridgeman H;Greenwell-Wild T;Zangerle-Murray T;Fife ME;Bouladoux N;Linley H;Brenchley L;Wemyss K;Calderon G;Hong BY;Break TJ;Bowdish DME;Lionakis MS;Jones SA;Trinchieri G;Diaz PI;Belkaid Y;Konkel JE;Moutsopoulos NM
- 通讯作者:Moutsopoulos NM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joanne Konkel其他文献
Donor-Derived, <em>I</em><em>n Vivo</em> T-Cell Expansion Using Granulocyte Transfusions after Cord Blood Transplant Induces Remission in Children with Relapsed, Refractory Acute Myeloid Leukemia and Is Associated with a Cytokine Release Syndrome
- DOI:
10.1182/blood-2022-163189 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Roisin Borrill;Helen Campbell;Denise Bonney;Ramya Nataraj;Madeleine Powys;Omima Abdalla Mustafa;Laura Kusyk;Tracy Hussell;Suzy Morton;Simon Stanworth;Kay Poulton;Joanne Konkel;Robert Wynn - 通讯作者:
Robert Wynn
Donor-Derived, emI/ememn Vivo/em T-Cell Expansion Using Granulocyte Transfusions after Cord Blood Transplant Induces Remission in Children with Relapsed, Refractory Acute Myeloid Leukemia and Is Associated with a Cytokine Release Syndrome
在脐血移植后使用粒细胞输注进行供体来源的 emI/ememn 体内 em T 细胞扩增可诱导复发性难治性急性髓系白血病儿童的缓解,并与细胞因子释放综合征相关。
- DOI:
10.1182/blood-2022-163189 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:23.100
- 作者:
Roisin Borrill;Helen Campbell;Denise Bonney;Ramya Nataraj;Madeleine Powys;Omima Abdalla Mustafa;Laura Kusyk;Tracy Hussell;Suzy Morton;Simon Stanworth;Kay Poulton;Joanne Konkel;Robert Wynn - 通讯作者:
Robert Wynn
Joanne Konkel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joanne Konkel', 18)}}的其他基金
Cutting-edge Spectral sorter to drive in-depth analysis of cell states and activity in complex tissue environments
尖端的光谱分选仪可推动复杂组织环境中细胞状态和活动的深入分析
- 批准号:
BB/V019287/1 - 财政年份:2021
- 资助金额:
$ 123.5万 - 项目类别:
Research Grant
相似国自然基金
基于智能预测控制的Barrier Bucket高频数字低电平系统关键技术研究
- 批准号:11975289
- 批准年份:2019
- 资助金额:62.0 万元
- 项目类别:面上项目
Barrier Bucket双环双频模式下的高精度踢轨控制系统关键技术研究
- 批准号:U1632141
- 批准年份:2016
- 资助金额:50.0 万元
- 项目类别:联合基金项目
相似海外基金
Enhancing Coastal Resilience through Participatory Transformation of Barrier Islands
通过屏障岛的参与式改造增强沿海地区的恢复能力
- 批准号:
2242572 - 财政年份:2024
- 资助金额:
$ 123.5万 - 项目类别:
Standard Grant
Glut1+ cancer associated fibroblasts enforce a metabolic barrier to tumor T cell infiltration
Glut1癌症相关成纤维细胞增强了肿瘤T细胞浸润的代谢屏障
- 批准号:
10752508 - 财政年份:2024
- 资助金额:
$ 123.5万 - 项目类别:
Breaking the Barrier: Mapping protein interactions in the bacterial outer membrane as targets for new antimicrobials
打破障碍:绘制细菌外膜中的蛋白质相互作用作为新抗菌药物的目标
- 批准号:
MR/Y012453/1 - 财政年份:2024
- 资助金额:
$ 123.5万 - 项目类别:
Research Grant
ICF: Enhancing Blood-Brain Barrier Opening with Ultrasound and Microwaves for Targeted Drug Delivery
ICF:利用超声波和微波增强血脑屏障开放以实现靶向药物输送
- 批准号:
MR/Z503848/1 - 财政年份:2024
- 资助金额:
$ 123.5万 - 项目类别:
Research Grant
Coating network and barrier property design strategies, for protection against hydrogen embrittlement
涂层网络和阻隔性能设计策略,以防止氢脆
- 批准号:
2902353 - 财政年份:2024
- 资助金额:
$ 123.5万 - 项目类别:
Studentship
Behind the barrier: using mathematics to understand the neuro-immune system
障碍背后:用数学来理解神经免疫系统
- 批准号:
DE240100650 - 财政年份:2024
- 资助金额:
$ 123.5万 - 项目类别:
Discovery Early Career Researcher Award
CAREER: Evaluating Theories of Polymer Crystallization by Directly Calculating the Nucleation Barrier in a Polymer Melt
职业:通过直接计算聚合物熔体中的成核势垒来评估聚合物结晶理论
- 批准号:
2338690 - 财政年份:2024
- 资助金额:
$ 123.5万 - 项目类别:
Continuing Grant
Gravel barrier resilience in a changing climate (#gravelbeach)
气候变化中的砾石屏障恢复能力(
- 批准号:
NE/Y50323X/1 - 财政年份:2024
- 资助金额:
$ 123.5万 - 项目类别:
Research Grant
Venom-derived blood-brain-barrier shuttles
毒液衍生的血脑屏障穿梭机
- 批准号:
DP230102707 - 财政年份:2023
- 资助金额:
$ 123.5万 - 项目类别:
Discovery Projects
Development of blood-brain barrier-penetrating oligosaccharides
穿透血脑屏障寡糖的开发
- 批准号:
23K11852 - 财政年份:2023
- 资助金额:
$ 123.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)